MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 109 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,816,156 | -20.5% | 152,410 | -34.9% | 0.04% | -14.0% |
| Q2 2023 | $6,060,513 | +25.3% | 234,268 | +16.3% | 0.04% | +16.2% |
| Q1 2023 | $4,837,148 | +23.2% | 201,380 | 0.0% | 0.04% | +23.3% |
| Q4 2022 | $3,926,910 | +16.8% | 201,380 | +25.8% | 0.03% | +7.1% |
| Q3 2022 | $3,362,000 | +5.1% | 160,037 | -2.6% | 0.03% | +16.7% |
| Q2 2022 | $3,199,000 | -15.5% | 164,387 | -4.4% | 0.02% | -4.0% |
| Q1 2022 | $3,786,000 | -17.1% | 171,915 | -39.9% | 0.02% | -13.8% |
| Q4 2021 | $4,566,000 | – | 286,240 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 1,621,118 | $38,939,254 | 45.05% |
| NEA Management Company, LLC | 4,186,243 | $100,553,557 | 6.95% |
| Frazier Life Sciences Management, L.P. | 3,860,107 | $92,719,770 | 6.71% |
| Prosight Management, LP | 567,826 | $13,639,181 | 6.47% |
| TANG CAPITAL MANAGEMENT LLC | 1,170,000 | $28,103,400 | 4.19% |
| Highlander Partners, L.P. | 122,980 | $2,953,980 | 4.00% |
| Novo Holdings A/S | 1,684,193 | $40,454,316 | 2.67% |
| CADIAN CAPITAL MANAGEMENT, LP | 734,922 | $17,652,826 | 1.10% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,032,335 | $48,816,687 | 1.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,939 | $2,544,655 | 1.05% |